pCLXSN-c-JUN Citations (2)

Originally described in: JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer.
Song W, Ma Y, Wang J, Brantley-Sieders D, Chen J Cancer Res. 2014 May 1;74(9):2444-54. doi: 10.1158/0008-5472.CAN-13-2136. Epub 2014 Mar 7. PubMed Journal

---

Articles Citing pCLXSN-c-JUN

Articles
The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis. Muller A, Dickmanns A, Resch C, Schakel K, Hailfinger S, Dobbelstein M, Schulze-Osthoff K, Kramer D. J Clin Invest. 2020 Jul 23. pii: 134217. doi: 10.1172/JCI134217. PubMed
Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress. Zhang W, Liu W, Jia L, Chen D, Chang I, Lake M, Bentolila LA, Wang CY. Mol Cell. 2021 May 20;81(10):2148-2165.e9. doi: 10.1016/j.molcel.2021.02.038. Epub 2021 Mar 19. PubMed

If you have published an article using this material, please email us at to have your article added to this page.